Enzo Biochem, Inc. (NYSE:ENZ) is much more than a highly respected clinical laboratory. Its lab is utilized extensively to demonstrate the benefits of gene-based products developed at Enzo Life Sciences. It also plays an important role in the development of and performance of tests used to support the on going trials of Enzo Therapeutics.
Enzo Therapeutics is a growing and expanding biotechnology company, currently conducting research that is on the forefront of several fields of medical science. Enzo Therapeutics is developing new products and therapies based on novel technology platforms for the treatment of a variety of diseases and disorders.
The business activities of Enzo Biochem, Inc. are performed by the companys three wholly owned subsidiaries . . . Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical
NOTE: After infection, HIV-1 runs a slow course in which immune T-cells (CD4+ cells) progressively disappear from the circulation. In the absence of treatment an infected individual loses the ability to mount an immune response. This loss of immune responsiveness leads to an increased susceptibility to infection that results in a complex of diseases know as AIDS and ultimately to death.
ENZ (which develops, produces and markets proprietary labeling and detection products for gene sequencing, genetic analysis and immunological research, among others), benefiting from increased emphasis on higher margin products.
The company total revenues for the first quarter of fiscal 2011 increased to $25.7 million, from $25.2 million a year ago, or 2%, despite slightly lower revenues at Life Sciences resulting from a program to emphasize higher margined products, and advanced 3% sequentially. Enzo Clinical Labs benefited from an increase in market share and a new provider contract.
For more information about this company please visit http://www.enzo.com
Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) reported the launch of a native iPad™ application that marks the first U.S. mobile banking application that visually goes beyond the traditional on-line banking interface of the few other iPad banking applications. In addition to the new iPad application, BBVA Compass also offers native mobile banking applications for Android™, BlackBerry® and iPhone™ users. Each of the applications for these mobile devices was built in house to provide greater flexibility and functionality.
Banco Bilbao Vizcaya Argentaria, S.A. engages in retail banking, asset management, private banking, and wholesale banking businesses in Spain and internationally.
Power3 Medical Products, Inc. (PWRM.OB) applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. The company has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject.
* Alzheimer's doesn't have any immediate cure, but remedies for indicators can be found and investigate carries on. Even though current Alzheimer treatment options cannot cease Alzheimer's disease from progressing, they're able to temporarily decrease the speed of the deterioration involving signs of illness in addition to advance quality of life for the people with Alzheimer's disease as well as all their caregivers. Today, there exists a international exertion under approach to finding better ways to take care of the condition, postponement its onset, and prevent it from escalating.
* Globally, breast cancer makes up 10.4% of all cancer incidences involving women, making it the most widespread type of non-skin melanoma in women of all ages and the fifth most common reason behind cancer death. In 2004, breast cancer brought about 519,000 deaths around the world (7% of cancer fatalities; nearly 1% of all deaths). Breast cancer is about hundred times more frequent in women compared with men, even though guys tend to have more serious outcomes due to delays in obtaining medical diagnosis.
* Parkinson's disease is really a problem that affects nerve cells, or neurons, inside of a section of the brain of which controls muscle motions. In Parkinson's, nerves which make an important chemical called dopamine die or do not work properly. Dopamine generally delivers impulses that assist synchronize a person's activities.
PWRM management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few. The bio-technology company previously delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii.
Furthermore, Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company.
The acquisition of Rozetta-Cell is expected to be completed in February 2011.
For more information about this company please visit http://www.power3medical.com
Flagstone Reinsurance Holdings SA (NYSE:FSR) has updated its estimate of claims relating to its exposure to the earthquake in New Zealand from $52.5 million to $75.5 million net of reinstatement premiums and retrocession. Flagstone’s loss estimate is based on its proprietary modeling analysis, the assessment of individual treaties and client data, third-party vendor models, and an updated estimated industry loss of $4.5 to $6 billion USD. The revision was due primarily to significant recently reported adjustments by cedants and conservative reserving assumptions by
Flagstone taking into consideration the significant extent of potential property damage.
Flagstone Reinsurance Holdings Limited, through its subsidiaries, operates as a reinsurance and insurance company worldwide.
Steelcase Inc. (NYSE:SCS) reported organizational changes to strengthen its position as a globally integrated enterprise. Jim Keane, president of the Steelcase Group, is assuming leadership of the Steelcase brand across the Americas and EMEA (Europe, the Middle East and Africa), which includes overseeing all product design and development, engineering, marketing and sales. Jim Mitchell, president of Steelcase International, will retain responsibility for sales and distribution across EMEA and will report to Jim Keane.
Steelcase Inc., together with its subsidiaries, engages in the design, manufacture, and marketing of office furniture for corporate, hospitality, and residential settings in North America and internationally.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).